U.S. stocks higher, Dow up 100 points. NASDAQ and S&P 500 also see gains. Energy shares up, cons

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) ("Acurx" or the "Company"), a late-stage b

Acurx Pharmaceuticals (NASDAQ:ACXP) shares down on Friday after reporting net loss for Q4 2025, but

Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.73) per share which beat the an

ACXP shares are falling Thursday as overbought signals trigger a pullback after Wednesday's 108%

Petco Health and Wellness (WOOF) reported strong Q4 sales, but missed earnings estimates. Other gain

Acurx Pharmaceuticals Inc shares are trading sharply higher Wednesday afternoon despite a lack of co

Acurx's Program in the Broader CDI Patient Population is Ready to Advance toPhase 3 Internationa

Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(1.23) per share which beat the an

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), is a late-sta

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) ("Acurx" or the "Company"), a late-stage b

HC Wainwright & Co. analyst Matthew Keller reiterates Acurx Pharmaceuticals (NASDAQ:ACXP) wit

The Paediatric Committee (PDCO) of the European Medicines Agency issued a positive opinion on Acurx&

HC Wainwright & Co. analyst Matthew Keller maintains Acurx Pharmaceuticals (NASDAQ:ACXP) with

Acurx's common stock is expected to begin trading on a post-split adjusted basis on August 5, 20

Shares of Acurx Pharmaceuticals inc. (NASDAQ: ACXP) are up on Tuesday following the publication of f

As previously reported, 15 out of 16 (94%) patients in Phase 2b in the Per Protocol Population exper

Results are from Acurx's ongoing scientific collaboration with Leiden University Medical Center

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s sessi

  On Monday, 369 companies set new 52-week lows.